Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ONESOURCE SPECIALTY PHARMA LTD.

NSE : ONESOURCEBSE : 544292ISIN CODE : INE013P01021Industry : Pharmaceuticals & DrugsHouse : Private

BSE1956.00-23.1 (-1.17 %)

PREV CLOSE ( ) 1979.10

OPEN PRICE ( ) 1988.45

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2351

TODAY'S LOW / HIGH ( )1949.65 2000.95

52 WK LOW / HIGH ( )1163.05 2249.65

NSE1953.90-27.8 (-1.4 %)

PREV CLOSE( ) 1981.70

OPEN PRICE ( ) 1970.00

BID PRICE (QTY) 1953.90 (290)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 92319

TODAY'S LOW / HIGH( ) 1947.00 2001.00

52 WK LOW / HIGH ( )1209.95 2248

Quarters

Select year

( in Million)

Particulars

Mar 2025

Dec 2024

Sep 2024

Mar 2024

Audited / UnAudited

UnAudited

Net Sales

4259.53

3925.63

679.8

731.43

Total Expenditure

2434.38

2493.49

678.57

759.43

PBIDT (Excl OI)

1825.15

1432.14

1.22

-28

Other Income

28.9

53.93

5.82

26.36

Operating Profit

1854.05

1486.07

7.04

-1.63

Interest

334.12

458.21

207.26

204.56

Exceptional Items

0.00

-1005.23

-0.21

PBDT

1519.93

22.63

-200.21

-206.41

Depreciation

684.91

687.65

190.61

195.29

Profit Before Tax

835.02

-665.02

-390.82

-401.7

Tax

-156.9

23.47

0.00

Provisions and contingencies

Profit After Tax

991.92

-688.49

-390.82

-401.7

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

985.02

-688.49

-390.82

-401.7

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

985.02

-688.49

-390.82

-401.7

Equity Capital

114.43

41.55

40.1

Face Value (IN RS)

Reserves

Calculated EPS

8.60

-6.01

-9.40

-10.01

Calculated EPS (Annualised)

34.43

-24.06

-37.62

-40.06

No of Public Share Holdings

75237274

71213780

% of Public Share Holdings

65.75

62.23

PBIDTM% (Excl OI)

42.84

36.48

0.18

-3.82

PBIDTM%

43.52

37.85

1.03

-0.22

PBDTM%

35.68

0.57

-29.45

-28.22

PBTM%

19.60

-16.94

-57.49

-54.91

PATM%

23.28

-17.53

-57.49

-54.91

Notes

Risk Disclosures on Derivatives

Quarterly Results

ONESOURCE SPECIALTY PHARMA LTD.